Physician profile
Jenna Molander
NPI 1508351230
$1,993.80
in general payments reported to CMS, 2019-2025
26 companies · $474 in 2025
The $474 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.37 · 2022: $130 · 2023: $500 · 2024: $866 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,727 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.90 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $458.52 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $203.01 | 2022-2024 | Endosee, Mara Console, Paragard T 380a |
| Mayne Pharma Commercial LLC | $176.97 | 2023-2025 | |
| Sage Therapeutics, LLC | $150.91 | 2022-2025 | Zurzuvae |
| Millicent US INC | $123.45 | 2024-2025 | Intrarosa, Femlyv |
| Exeltis, USA INC. | $115.01 | 2023-2025 | Slynd |
| Pfizer INC. | $91.90 | 2022-2024 | |
| Organon LLC | $78.01 | 2023-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $76.20 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $60.70 | 2023-2025 | |
| Abbvie INC. | $58.37 | 2022-2023 | |
| Hologic Sales and Service, LLC | $47.37 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Gynesonics, INC. | $44.50 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $38.65 | 2024-2025 | Pico 14 |
| Meditrina | $34.07 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.07 | 2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $30.88 | 2024 | Twirla |
| Shield Therapeutics INC | $29.95 | 2023-2024 | Accrufer |
| Mimedx Group, INC. | $29.91 | 2025 | |
| Myovant Sciences INC. | $23.80 | 2022 | |
| Daiichi Sankyo INC. | $20.48 | 2021 | |
| Medtronic, INC. | $19.07 | 2023 | Truclear |
| Mylan Pharmaceuticals INC. | $16.30 | 2022 | |
| Therapeuticsmd, INC. | $15.00 | 2022 | |
| Exact Sciences Corporation | $14.81 | 2025 | Cologuard Collection Kit |
| Alydia Health | $3.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Molander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.